Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
NSC Norfolk Southern Corp
WM Waste Management Inc
ITOS Iteos Therapeutics Inc
CCLD CareCloud Inc
JEF Jefferies Financial Group Inc
RSASF Resaas Services Inc
VRNT Verint Systems Inc
TRHC Tabula Rasa HealthCare Inc
ILMN Illumina Inc
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.

Price
Delayed
$768.48
Day's Change
-12.38 (-1.59%)
Bid
--
Ask
--
B/A Size
--
Day's High
778.05
Day's Low
763.15
Volume
(Average)

Today's volume of 538,871 shares is on pace to be in-line with REGN's 10-day average volume of 724,147 shares.

538,871

CDW Corp. Stock Outperforms Market On Strong Trading Day

4:43 pm ET October 17, 2022 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of CDW Corp. (CDW) rallied 3.36% to $159.26 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 2.65% to 3,677.95 and the Dow Jones Industrial Average rising 1.86% to 30,185.82. CDW Corp. closed $49.45 short of its 52-week high ($208.71), which the company reached on January 4th.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Apple Inc. (AAPL) rose 2.91% to $142.41, HP Inc. (HPQ) rose 0.98% to $25.69, and TD SYNNEX Corp. (SNX) rose 3.44% to $85.66. Trading volume (775,425) eclipsed its 50-day average volume of 756,138.

Data source: Dow Jones Market Data, FactSet. Data compiled October 17, 2022.

	

(END) Dow Jones Newswires

October 17, 2022 16:43 ET (20:43 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.